When analyzed within individual diagnostic groups, plasma levels of Aβ42 were decreased in APOE ε4 carriers in controls (p < 0.001) and SCD (p < 0.001), but not in MCI and AD dementia patients. This evidence concerns the gene APOE and Schnyder corneal dystrophy.